Sort   by:  
 Page size 
UnknownPlateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.
Not available
S-EPMC12357967 | biostudies-literature
UnknownDorsal attention network centrality increases during recovery from acute stress exposure.
Not available
S-EPMC8214139 | biostudies-literature
UnknownCognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.
Not available
S-EPMC5987993 | biostudies-literature
UnknownA randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
Not available
S-EPMC9574229 | biostudies-literature
UnknownTreatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosis.
Not available
S-EPMC12092944 | biostudies-literature
UnknownNo Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients.
Not available
S-EPMC6220078 | biostudies-literature
UnknownGlutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning.
Not available
S-EPMC9066676 | biostudies-literature
UnknownEvaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis.
Not available
S-EPMC11319410 | biostudies-literature
UnknownRegional cerebellar atrophy related to disability and cognitive progression in multiple sclerosis.
Not available
S-EPMC12264214 | biostudies-literature
UnknownResting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS.
Not available
S-EPMC6875827 | biostudies-literature
Sort   by:  
 Page size